![Brian Nichols](https://investorplace.com/wp-content/uploads/userphoto/17347.jpg?20240829a)
Recent Articles
3 Reasons To Buy QCOM Stock
By
Brian Nichols, InvestorPlace Contributor
Sure QCOM stock got beat up after earnings, but with a dividend that keeps growing and plenty of long-term growth opportunities, it's a clear buy right now.
CenturyLink: CTL Stock Is Perfect for Income Investors
By
Brian Nichols, InvestorPlace Contributor
CTL stock dividend is not only sustainable but has plenty of room to grow as the company's fundamentals improve.
Celldex Therapeutics, Inc.: CLDX Stock Jumps 13%, Preps for More Gains
By
Brian Nichols, InvestorPlace Contributor
Celldex Therapeutics' (CLDX) brain-cancer drug Rintega is waiting on data and filing an NDA -- and that ultimately bodes well for CLDX stock.
8 Big Facebook Projects to Catapult FB Stock
By
Brian Nichols, InvestorPlace Contributor
Facebook (FB) stock could keep going higher if these eight Facebook catalysts materialize.
Alibaba vs. Amazon: Which Is the Better Stock?
By
Brian Nichols, InvestorPlace Contributor
Based on growth, outlook, and valuation, the best investment between AMZN and BABA is obvious.
![Louis Navellier's Market 360 logo](https://investorplace.com/wp-content/uploads/2021/10/lnel-logo-new-175x25-1.png)
Join Louis Navellier’s Market 360 — FREE!
Get Louis Navellier’s take on the news and events impacting the market, plus his top stock picks.